‹ All stocks

Drugs Made In America Acquisition II Corp. Right

DMIIR · NASDAQ · Financial Services

$0.06

▲ $0.01 (27.63%)

1D 7D 1M 3M 1Y All

Day range

$0.06 – $0.06

Year range

$0.05 – $0.16

Open

$0.06

Previous close

$0.05

Market cap

$4.46M

Volume (24h)

$403

Volume (52w)

$26

Performance

▲ 27.63%

▼ -8.55%

▼ -24.47%

▼ -28.67%

▼ -57.20%

YTD

▼ -54.14%

▼ -57.20%

All-time

▼ -57.20%

Key statistics

P/E ratio

—

EPS (TTM)

—

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

69.5M

About Drugs Made In America Acquisition II Corp. Right

Drugs Made In America Acquisition II Corp. currently possesses no substantial operational activities. Its core objective is to execute a strategic business combination—such as a merger, acquisition, or other corporate transaction—with one or more existing enterprises. This entity was established in 2024 and is headquartered in Fort Lauderdale, Florida.

Visit website

Country: United States of America

BRK-B Berkshire Hathaway	$504.26	0.75%
JPM JPMorgan Chase & Co.	$332.38	-0.24%
V Visa	$369.71	2.74%
MA Mastercard Incorporated	$564.59	2.65%
BAC Bank of America	$54.00	0.50%